Health and Happiness (H&H) International Holdings (SEHK:1112) has issued new earnings guidance for the six months to 30 June 2026, indicating Reported Net Profit growth of more than 7 times compared with last year’s low base.
See our latest analysis for Health and Happiness (H&H) International Holdings.
The upbeat earnings guidance comes after a sharp 33.57% 1 month share price return and a 13.55% year to date share price return. The 1 year total shareholder return of 38.67% and 3 year total shareholder return of 71% suggest momentum has been building over a longer period, despite a decline of 34.32% on a 5 year total shareholder return basis.
If this kind of rebound has your attention, it could be a good moment to widen your watchlist and look at 106 top founder-led companies
Bulls point to Health and Happiness (H&H) International Holdings’ sharp rebound and very large guided profit jump, while bears point to the weak 5 year return and prior low base. What does the current valuation say about which side has the stronger case?
Health and Happiness (H&H) International Holdings closed at HK$14.92, and on that price the stock trades on a P/E of 42.4x, which is well above both the Hong Kong Food industry average of 12.1x and the peer average of 31.2x.
The P/E ratio compares the company’s share price with its earnings per share, so a higher multiple usually reflects higher expectations for profit relative to current earnings. For Health and Happiness (H&H) International Holdings, the market is putting a premium price on those earnings, while current return on equity of 3.3% is described as low and the company has only recently returned to profitability after a period that included a large one off loss of CN¥335.6m.
Against that backdrop, the P/E of 42.4x stands out as expensive versus the sector and the estimated fair P/E of 24.2x. That fair ratio level suggests a materially lower multiple is the point the market could move towards if sentiment and expectations around future earnings moderation or normalisation take hold rather than expanding further.
Explore the SWS fair ratio for Health and Happiness (H&H) International Holdings
Result: Price-to-Earnings of 42.4x (OVERVALUED)
However, the high P/E and reliance on Mainland China for most revenue mean any earnings disappointment or regional setback could quickly challenge the recent momentum in Health and Happiness (H&H) International Holdings.
Find out about the key risks to this Health and Happiness (H&H) International Holdings narrative.
While Health and Happiness (H&H) International Holdings looks expensive on a 42.4x P/E, the SWS DCF model points in a different direction, with an estimated fair value of HK$74.17 versus the current HK$14.92. This implies the stock trades at a steep discount. Which lens do you trust more when expectations are this far apart?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Health and Happiness (H&H) International Holdings for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 220 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
With sentiment clearly split on Health and Happiness (H&H) International Holdings, this is a good moment to move fast, review the key risks and rewards, and shape your own view with the 4 key rewards and 2 important warning signs
If Health and Happiness (H&H) International Holdings is on your radar, this is a good time to broaden your opportunity set and compare it with other focused ideas.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com